Scientists are seeking to understand the virus, characterize infectivity, and understand its mechanism of action in their quest to develop therapeutics and vaccines. Key to this process are quantifiable assays that provide robust data for all aspects of research.
LI-COR Biosciences continues to support virology researchers with products, tools, and services to better understand SARS-CoV-2 and other viruses. Traditionally, infectivity of viruses that exhibit cytopathic effect (CPE) has been characterized using plaque assays. While effective, these methods can be tedious, time-consuming, and the results are subject to human error.
Near-infrared (NIR) Western Blots and In-Cell Western™ Assays provide a high-quality, reliable means to get answers to a variety of assays that are key to the study of viruses like SARS-CoV-2.
“Our In-Cell Western Assay combines the specificity of Western blotting with the replicability and throughput of an ELISA,” says Jeff Harford, LI-COR senior product marketing manager. “This results in the ...
